Table 1 Demographic and clinicopathologic characteristics of 152 subjects comprising IHC study cohort
From: Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
| Ā | IHC cohort | |
|---|---|---|
| Ā | BCa (%) n = 142 | Controls (%) n = 10 |
Median age (range, y) | 73 (30ā94) | 29 (15ā48) |
Median age (range, y) | 73 (30ā94) | 29 (15ā48) |
Race | Ā | Ā |
āāCaucasian | 134 (94%) | N/A |
āāAfrican American | 5 (4%) | N/A |
āāOther | 3 (2%) | N/A |
Median follow-up (months) | 13 | 11 |
Clinical stage | Ā | Ā |
āāTis | 16 (11%) | Ā |
āāTa | 6 (4%) | Ā |
āāT1 | 60 (42%) | Ā |
āāā„T2 | 60 (42%) | Ā |
Tumor grade | Ā | Ā |
āāLow | 11 (8%) | Ā |
āāHigh | 131 (92%) | Ā |